statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Structure Therapeutics Inc. (NASDAQ:GPCR  Get Free Report) fell 3.4% during trading on Wednesday . The company traded as low as $40.66 and last traded at $40.72. 61,403 shares traded hands...

Structure Therapeutics (NASDAQ:GPCR) Stock Price Down 3.4%

Structure Therapeutics Inc. (NASDAQ:GPCR  Get Free Report)s share price gapped up prior to trading on Thursday . The stock had previously closed at $38.63, but opened at $41.10...

Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up to $38.63

SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...

Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference

Topline GSBR-1290 Phase 2a 12-week obesity data, as well as data from formulation bridging and titration optimization study, on track for latter half of the second quarter 2024 Phase 2b study in...

Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights

Fmr LLC raised its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR  Free Report) by 28.5% in the 3rd quarter, according to the company in its most recent disclosure with the...

Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Acquired by Fmr LLC

Structure Therapeutics Inc. (NASDAQ:GPCR  Get Free Report) has been assigned a consensus recommendation of Buy from the seven ratings firms that are currently covering the firm...

Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of "Buy" by Analysts

TD Asset Management Inc boosted its holdings in shares of Structure Therapeutics Inc. (NASDAQ:GPCR  Free Report) by 109.3% in the third quarter, according to the company in its most recent 13F...

TD Asset Management Inc Buys 79,467 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR)

Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. The company was founded by Raymond Stevens in February 2019 and is headquartered in South San Francisco, CA.

Volume	222,956.00
52-Wk High	$75.02
52-Wk Low	$21.79

GPCR Structure Therapeutics Inc - ADR

About

Feed

News

Sentiment

Fundamentals